Capstone Holding announced a $3.25M draw from its existing convertible note facility. This new tranche of capital will support the company’s recently signed letter of intent to acquire a multi-location stone distributor with approximately $15M in annual revenue. The transaction is expected to be immediately accretive to revenue and EBITDA. This financing accelerates Capstone’s momentum as the company advances toward its $100M revenue run-rate target for 2026. Key Highlights: Funding: $3.25M cash draw under Capstone’s existing $10M convertible note facility. Terms: Quarterly cash amortization beginning after 90 days; $1.10 fixed conversion price. Flexible Capital: Strengthens Capstone’s ability to move decisively on high-quality, accretive acquisitions while preserving balance-sheet strength and flexibility. Disciplined Financing: Demonstrates Capstone’s commitment to prudent, structured capital deployment focused on long-term value creation. Investor Partnership: Reinforces deep institutional investor confidence in Capstone’s M&A strategy and growth trajectory. Acquisition Momentum: Advances execution of the recently announced LOI to acquire an approximately $15M multi-location stone distributor.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPS:
- Capstone Therapeutics Issues Second Convertible Note
- Capstone Holding files to sell 4.31M shares of common stock for holders
- Capstone Therapeutics achieves milestones in Carolina Stone integration
- Capstone Holding signs LOI to acquire stone distribution business
- Capstone Therapeutics Strengthens Balance Sheet with Debt Exchange
